Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SPSC
|
Archie C. Black
Director |
SELL
Open market or private sale
|
Direct | 4,251 Reduced 4.23% |
$577,710
$135.9 p/Share
|
Jan 31
2023 |
|
CPK
|
John R Schimkaitis |
SELL
Open market or private sale
|
Direct | 4,629 Reduced 5.47% |
$578,995
$125.08 p/Share
|
Jan 31
2023 |
|
VYGR
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 185,000 Reduced 3.7% |
$1,711,250
$9.25 p/Share
|
Jan 31
2023 |
|
XMTR
|
James M Rallo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.51% |
$343,900
$34.39 p/Share
|
Jan 31
2023 |
|
KDNY
|
Eric Dobmeier
President, CEO |
SELL
Open market or private sale
|
Direct | 7,688 Reduced 2.59% |
$189,739
$24.68 p/Share
|
Jan 31
2023 |
|
ORGN
|
Boon Sim
Director |
SELL
Open market or private sale
|
Direct | 64,300 Reduced 1.26% |
$389,015
$6.05 p/Share
|
Jan 31
2023 |
|
VIR
|
Svf Endurance (Cayman) LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 73,883 Reduced 0.0% |
$2,156,644
$29.19 p/Share
|
Jan 31
2023 |
|
LEVI
|
Lisa Stirling
Global Controller |
SELL
Open market or private sale
|
Direct | 5,017 Reduced 14.98% |
$90,506
$18.04 p/Share
|
Jan 31
2023 |
|
PLRX
|
Bernard Coulie
President and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.88% |
$523,800
$34.92 p/Share
|
Jan 31
2023 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 33.66% |
$1,481,550
$42.33 p/Share
|
Jan 31
2023 |
|
AA
|
Harden Sonya Elam
EVP & Chief Ext. Aff. Officer |
SELL
Open market or private sale
|
Direct | 4,514 Reduced 13.3% |
$234,141
$51.87 p/Share
|
Jan 31
2023 |
|
FULT
|
George W Hodges |
SELL
Open market or private sale
|
Indirect | 6,799 Reduced 0.0% |
$112,659
$16.57 p/Share
|
Jan 31
2023 |
|
NATI
|
Scott Arthur Rust
Executive Vice President |
SELL
Open market or private sale
|
Direct | 2,094 Reduced 3.66% |
$113,599
$54.25 p/Share
|
Jan 31
2023 |
|
PFS
|
Christopher P Martin
Executive Chairman |
SELL
Open market or private sale
|
Direct | 51,881 Reduced 8.84% |
$1,211,421
$23.35 p/Share
|
Jan 31
2023 |
|
URGN
|
Jason Drew Smith
General Counsel |
SELL
Open market or private sale
|
Direct | 1,636 Reduced 10.55% |
$16,556
$10.12 p/Share
|
Jan 31
2023 |
|
URGN
|
Mark Schoenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,900 Reduced 1.26% |
$19,228
$10.12 p/Share
|
Jan 31
2023 |
|
NATI
|
Eric Howard Starkloff
President & CEO |
SELL
Open market or private sale
|
Direct | 35,896 Reduced 9.66% |
$1,947,358
$54.25 p/Share
|
Jan 31
2023 |
|
IONS
|
Patrick R. O'Neil
EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 10.19% |
$178,695
$39.71 p/Share
|
Jan 31
2023 |
|
PGR
|
Daniel P Mascaro
Vice Pres, Secretary and CLO |
SELL
Open market or private sale
|
Direct | 3,284 Reduced 7.79% |
$445,737
$135.73 p/Share
|
Jan 31
2023 |
|
SXI
|
David A. Dunbar
President/CEO/Chairman |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 0.0% |
$287,500
$115.0 p/Share
|
Jan 31
2023 |
|
AEHR
|
Mario M Rosati |
SELL
Open market or private sale
|
Direct | 64,108 Reduced 94.54% |
$2,194,416
$34.23 p/Share
|
Jan 31
2023 |
|
AEHR
|
Mario M Rosati |
SELL
Open market or private sale
|
Indirect | 27,000 Reduced 0.0% |
$937,440
$34.72 p/Share
|
Jan 31
2023 |
|
AEHR
|
Laura Oliphant
Director |
SELL
Open market or private sale
|
Indirect | 504 Reduced 0.0% |
$17,080
$33.89 p/Share
|
Jan 31
2023 |
|
INCY
|
Maria E Pasquale
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 802 Reduced 1.16% |
$67,416
$84.06 p/Share
|
Jan 31
2023 |
|
PTCT
|
Mark Elliott Boulding
EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct | 812 Reduced 1.07% |
$37,051
$45.63 p/Share
|
Jan 31
2023 |
|
VRTX
|
Bastiano Sanna
EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct | 106 Reduced 0.28% |
$34,450
$325.0 p/Share
|
Jan 31
2023 |
|
HZO
|
Clint Moore |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 16.39% |
$153,300
$30.66 p/Share
|
Jan 31
2023 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct | 630 Reduced 0.98% |
$28,746
$45.63 p/Share
|
Jan 31
2023 |
|
PTCT
|
Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect | 28 Reduced 0.0% |
$1,277
$45.63 p/Share
|
Jan 31
2023 |
|
DOMA
|
Maxwell Simkoff
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 25,437 Reduced 0.0% |
$17,805
$0.7 p/Share
|
Jan 31
2023 |
|
SLGN
|
Thomas James Snyder
President - Silgan Containers |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 25.42% |
$1,067,600
$53.38 p/Share
|
Jan 31
2023 |
|
CMA
|
Cassandra M. Mc Kinney
EVP |
SELL
Open market or private sale
|
Direct | 362 Reduced 5.47% |
$26,317
$72.7 p/Share
|
Jan 31
2023 |
|
SPXC
|
Na Tausha Heleena White
VP AND CHRO |
SELL
Open market or private sale
|
Direct | 13,022 Reduced 27.98% |
$976,650
$75.0 p/Share
|
Jan 31
2023 |
|
NTCT
|
Michael Szabados
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 14.57% |
$157,150
$31.43 p/Share
|
Jan 31
2023 |
|
VRTX
|
Bruce I Sachs
Director |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 2.83% |
$390,012
$325.01 p/Share
|
Jan 31
2023 |
|
PTCT
|
Christine Marie Utter
SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 325 Reduced 0.85% |
$14,829
$45.63 p/Share
|
Jan 31
2023 |
|
PTCT
|
Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,320 Reduced 1.37% |
$105,861
$45.63 p/Share
|
Jan 31
2023 |
|
PTCT
|
Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 301 Reduced 0.0% |
$13,734
$45.63 p/Share
|
Jan 31
2023 |
|
PGNY
|
David J Schlanger
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,285 Reduced 1.69% |
$44,975
$35.0 p/Share
|
Jan 31
2023 |
|
PTCT
|
Eric Pauwels
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 375 Reduced 0.57% |
$17,111
$45.63 p/Share
|
Jan 31
2023 |
|
BC
|
David V Singer
Director |
SELL
Open market or private sale
|
Direct | 171 Reduced 0.8% |
$14,266
$83.43 p/Share
|
Jan 31
2023 |
|
PTCT
|
Emily Luisa Hill
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 575 Reduced 1.23% |
$26,237
$45.63 p/Share
|
Jan 31
2023 |
|
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 93,692 Reduced 0.8% |
$7,195,545
$76.8 p/Share
|
Jan 31
2023 |
|
PGNY
|
Peter Anevski
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 735 Reduced 0.33% |
$25,725
$35.0 p/Share
|
Jan 31
2023 |
|
PGNY
|
Peter Anevski
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 184 Reduced 0.0% |
$6,440
$35.0 p/Share
|
Jan 31
2023 |
|
PRT
|
Boaz Energy Ii, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 11,000 Reduced 0.2% |
$84,150
$7.65 p/Share
|
Jan 31
2023 |
|
TCX
|
Blacksheep Master Fund Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,700 Reduced 0.43% |
$157,168
$33.44 p/Share
|
Jan 31
2023 |
|
HTBI
|
Sidney A. Biesecker
Director |
SELL
Open market or private sale
|
Direct | 2,106 Reduced 6.07% |
$56,862
$27.0 p/Share
|
Jan 31
2023 |
|
NBIX
|
Matt Abernethy
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,283 Reduced 5.67% |
$141,104
$109.98 p/Share
|
Jan 31
2023 |
|
FICO
|
Thomas A. Bowers
Executive Vice President |
SELL
Open market or private sale
|
Direct | 13,491 Reduced 88.14% |
$8,786,958
$651.32 p/Share
|
Jan 31
2023 |